8:45am ET
Investing
Insiders Are Loving These 5 Tech and Biotech Stocks
Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with huge share purchases.
Companies
/Healthcare
Tenaya Therapeutics Inc
$0.69
▼ $0.01 (−0.73%) today
Markets closed · 3:49pm ET
Today · % change
Fundamentals
Market Cap
$155.9M
Revenue (TTM)
$1.3M
EPS (TTM)
$-0.51
52-Week Range
$1 – $2
Street Target
$3.20
About Tenaya Therapeutics
Based in South San Francisco, California, Tenaya Therapeutics is at the forefront of biotechnology with a focus on developing innovative therapies for heart disease. Leveraging cutting-edge platforms in cellular regeneration, gene therapy, and precision medicine, Tenaya is working on a range of treatments. These include gene therapies for specific types of cardiomyopathy and a small molecule for heart failure, alongside pioneering efforts in cardiac regeneration to help patients recover from heart failure caused by myocardial infarction. Founded in 2016, Tenaya aims to transform the landscape of cardiovascular disease treatment.
TNYA Coverage
8:45am ET
Investing
Insiders Are Loading Up on These 4 Biotech Stocks Now
Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the past week.
8:49am ET
Investing
5 Penny Stocks With 250% Upside in 1 Year According to Wall Street
Penny stocks represent an interesting investment opportunity. These stocks typically represent small companies or companies that are early in the development stages. But isn’t that how you make it big in the…
11:20am ET
Investing
Insider Buying: Taking a Controlling Stake in a Struggling Retailer?
A beneficial owner stepped up and took a controlling stake in a struggling retailer, while public offerings of stock prompted insider buying at some biotech companies.